UPDATE ON INTERXON (XON)

Interxon (XON): The stock was up almost 25% of Friday after declaring Q4 earnings on Thursday, 3/1/18. I included XON in my blog portfolio about one and half year ago on 7/4/2016. As I said in my January blog, Interxon is the only company in my blog portfolio which has lost almost 40% of its value and still holding in my portfolio! The good thing is, the company has started working in the direction of generating shareholder value rather than just storytelling as the company updated in the earnings call. 
  • Q4 Revenues: $77.0 million, an increase of 67% over the 4th quarter of 2016.
  • Q4 Loss: $27.3 million or $(0.23) per basic share, including non-cash charges of $41.5 million.

For the whole year (2017)
  • Total revenues: $231.0 million, an increase of 21% over 2016.
  • Net loss of $117.0 million or $(0.98) per basic share, including non-cash charges of $107.5 million.

Company Business Highlight
  • The energy team achieved cash positive scalable yields in two multibillion-dollar hydrocarbons from its Methane Bioconversion Platform (MBP), along with increasing yields on other targets. 
  • Precigen, a wholly owned subsidiary, commenced a therapeutic vaccine program based on its AdenoVerse™ platform and established a generalized system for Point of Care CAR-T cells that, based on in vitro and in vivo studies, offers the promise of outperforming currently available approaches, at considerably lower price.
  • The team has developed numerous therapeutic candidates targeting not only cancer but also autoimmune and infectious targets, while preparing for the commencement of multiple clinical trials in 2018.
  • Xogenex, a majority-owned subsidiary of Precigen, was authorized by the U.S. Food and Drug Administration (FDA) to commence its Phase 1 trial of the gene therapy INXN-4001, which management believe is the world's first multigene cardiac therapeutic candidate expressing proteins from three effector genes for the treatment of heart disease.

My View: I have been holding XON with patience for more than 1.5 years and there is reason(s) behind it. Obviously, it has been painful for shareholders to see a company’s stock keep plummeting. I think 2018 and 2019 should be the year of company’s turn-around. If they can execute as planned, it can be another bagger. I still have some stocks and some call options and planning to accumulate in the coming days. However, I do not hesitate to take profit/loss whenever required. That’s part of my strategy – not to get emotionally involved with any stock. If the company do not succeed in the plan I may get out. But as I have said before, this is a stock which needs lot of patience. For patience investors, it deserves a position in the portfolio for long run.

Comments

Post a Comment

Popular Post

Shesa's JUN 2025 Investment Blog

By Shesa Nayak U.S. Stock Market Update   The U.S. stock market had an incredible month of May. The S&P 500 added more than 5% in May, while Nasdaq was the star performer blasting 9.5% . Most of the gains were driven by tech and AI stocks. Despite tariff concerns, strong corporate earnings (about 12.5% Q1 growth) and a stable labor market supported stock market optimism. After a  marathon run in May, the U.S. stock market in June has shown resilience amid trade tensions, economic uncertainties and high intensity of Geopolitical tensions .  Israel, Iran War : Israel bombarded Iran and killed many of their senior leaders and Iran retaliated. The war intensified over the weekend between both nations. Israel has also attacked some of the oil fields. Wall Street was jittered last Friday due to the war. The reason is, if both these countries continue to battle then it may impact oil supply and oil prices would go up. Lat Friday, crude oil jumped around 10%. The worry ...
Read more

U.S Stock Market Weekend Update - 5|31|25

The month of May ended with a spectacular market performance. The S&P 500 added more than 5% this month, while the Nasdaq rocketed 9.5% in that time. Both are on track to notch their best months since November 2023. The Dow Jones gained 3% on the month. For the week, the S&P 500 advanced 1.5%, while the 30-stock Dow is up 1% and  Nasdaq went up 1.9%. The biggest ever was another great earnings report. I will write about it later. On the economic front, the Consumer Confidence Index for May 27, 2025, rose to 98.0 from 85.7 in April. This is the highest ever increase of consumer confidence in a single month . The Federal reserve - FOMC minutes  from May 7, FOMC that showed a cautious approach due to increased economic uncertainty. Officials noted solid economic growth and labor market but highlighted rising risks of higher inflation and unemployment, partly due to tariff uncertainties. The last three months inflation has been receding but FED is...
Read more

Shesa's Weekend Update - 6|29|25

We saw a fantastic week for the stock market. The S&P 500 and Nasdaq hit record highs on June 27 , 2025, with the S&P 500 closing at 6,173, up 3.32% for the week, and the Nasdaq closed at 20273.46, up 4.36% . The Dow gained 2.6%. Stocks rallied due to easing Middle East tensions, trade deal optimism with China (Trump said deal was signed - framework), and expectations of Federal Reserve rate cuts.  There were  211 new small-cap stocks added to the Russell 2000 Index on June 27, 2025 which will start trading in Russell index starting tomorrow, Jun 30.  A glance to the Economic Report last week The Manufacturing PMI index came at 52 vs.51 expected. The Services PMI came at 53.1 vs. 53 expected. All comfortably above 50, signaling ongoing expansion in U.S. economic activity. The economy remains on solid footing. The Consumer Confidence Index for June 2025 was released on Tuesday, June 24, 2025. It dropped to 93.0 from 98.4 in May, below the expected 99.4.  Per...
Read more